Cargando…
Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1
Pain is the significant presenting symptom in Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Activation of urothelial protease activated receptor 4 (PAR4) causes pain through release of urothelial macrophage migration inhibitory factor (MIF). High Mobility Group Box-1 (HMGB1), a chromatin-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806866/ https://www.ncbi.nlm.nih.gov/pubmed/27010488 http://dx.doi.org/10.1371/journal.pone.0152055 |
_version_ | 1782423298679767040 |
---|---|
author | Kouzoukas, Dimitrios E. Ma, Fei Meyer-Siegler, Katherine L. Westlund, Karin N. Hunt, David E. Vera, Pedro L. |
author_facet | Kouzoukas, Dimitrios E. Ma, Fei Meyer-Siegler, Katherine L. Westlund, Karin N. Hunt, David E. Vera, Pedro L. |
author_sort | Kouzoukas, Dimitrios E. |
collection | PubMed |
description | Pain is the significant presenting symptom in Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Activation of urothelial protease activated receptor 4 (PAR4) causes pain through release of urothelial macrophage migration inhibitory factor (MIF). High Mobility Group Box-1 (HMGB1), a chromatin-binding protein, mediates bladder pain (but not inflammation) in an experimental model (cyclophosphamide) of cystitis. To determine if PAR4-induced bladder hypersensitivity depends on HMGB1 downstream, we tested whether: 1) bladder PAR4 stimulation affected urothelial HMGB1 release; 2) blocking MIF inhibited urothelial HMGB1 release; and 3) blocking HMGB1 prevented PAR4-induced bladder hypersensitivity. HMGB1 release was examined in immortalized human urothelial cultures (UROtsa) exposed to PAR4-activating peptide (PAR4-AP; 100 μM; 2 hours) or scrambled control peptide. Female C57BL/6 mice, pretreated with a HMGB1 inhibitor (glycyrrhizin: 50 mg/kg; ip) or vehicle, received intravesical PAR4-AP or a control peptide (100 μM; 1 hour) to determine 1) HMGB1 levels at 1 hour in the intravesical fluid (released HMGB1) and urothelium, and 2) abdominal hypersensitivity to von Frey filament stimulation 24 hours later. We also tested mice pretreated with a MIF blocker (ISO-1: 20 mg/kg; ip) to determine whether MIF mediated PAR4-induced urothelial HMGB1 release. PAR4-AP triggered HMGB1 release from human (in vitro) and mice (in vivo) urothelial cells. Intravesical PAR4 activation elicited abdominal hypersensitivity in mice that was prevented by blocking HMGB1. MIF inhibition prevented PAR4-mediated HMGB1 release from mouse urothelium. Urothelial MIF and HGMB1 represent novel targets for therapeutic intervention in bladder pain conditions. |
format | Online Article Text |
id | pubmed-4806866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48068662016-03-25 Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 Kouzoukas, Dimitrios E. Ma, Fei Meyer-Siegler, Katherine L. Westlund, Karin N. Hunt, David E. Vera, Pedro L. PLoS One Research Article Pain is the significant presenting symptom in Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Activation of urothelial protease activated receptor 4 (PAR4) causes pain through release of urothelial macrophage migration inhibitory factor (MIF). High Mobility Group Box-1 (HMGB1), a chromatin-binding protein, mediates bladder pain (but not inflammation) in an experimental model (cyclophosphamide) of cystitis. To determine if PAR4-induced bladder hypersensitivity depends on HMGB1 downstream, we tested whether: 1) bladder PAR4 stimulation affected urothelial HMGB1 release; 2) blocking MIF inhibited urothelial HMGB1 release; and 3) blocking HMGB1 prevented PAR4-induced bladder hypersensitivity. HMGB1 release was examined in immortalized human urothelial cultures (UROtsa) exposed to PAR4-activating peptide (PAR4-AP; 100 μM; 2 hours) or scrambled control peptide. Female C57BL/6 mice, pretreated with a HMGB1 inhibitor (glycyrrhizin: 50 mg/kg; ip) or vehicle, received intravesical PAR4-AP or a control peptide (100 μM; 1 hour) to determine 1) HMGB1 levels at 1 hour in the intravesical fluid (released HMGB1) and urothelium, and 2) abdominal hypersensitivity to von Frey filament stimulation 24 hours later. We also tested mice pretreated with a MIF blocker (ISO-1: 20 mg/kg; ip) to determine whether MIF mediated PAR4-induced urothelial HMGB1 release. PAR4-AP triggered HMGB1 release from human (in vitro) and mice (in vivo) urothelial cells. Intravesical PAR4 activation elicited abdominal hypersensitivity in mice that was prevented by blocking HMGB1. MIF inhibition prevented PAR4-mediated HMGB1 release from mouse urothelium. Urothelial MIF and HGMB1 represent novel targets for therapeutic intervention in bladder pain conditions. Public Library of Science 2016-03-24 /pmc/articles/PMC4806866/ /pubmed/27010488 http://dx.doi.org/10.1371/journal.pone.0152055 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication. |
spellingShingle | Research Article Kouzoukas, Dimitrios E. Ma, Fei Meyer-Siegler, Katherine L. Westlund, Karin N. Hunt, David E. Vera, Pedro L. Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title | Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title_full | Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title_fullStr | Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title_full_unstemmed | Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title_short | Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1 |
title_sort | protease-activated receptor 4 induces bladder pain through high mobility group box-1 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806866/ https://www.ncbi.nlm.nih.gov/pubmed/27010488 http://dx.doi.org/10.1371/journal.pone.0152055 |
work_keys_str_mv | AT kouzoukasdimitriose proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 AT mafei proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 AT meyersieglerkatherinel proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 AT westlundkarinn proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 AT huntdavide proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 AT verapedrol proteaseactivatedreceptor4inducesbladderpainthroughhighmobilitygroupbox1 |